Aruna Kamineni, PhD, MPH

“I'm working on reducing cancer through better screening. I collaborate with researchers nationwide on studies that will make screening more effective, patient-friendly, and personalized.”

Aruna Kamineni, PhD, MPH

Assistant Investigator, Kaiser Permanente Washington Health Research Institute

Aruna.S.Kamineni@kp.org
206-287-2922

Curriculum vitae (CV)

Biography

Aruna Kamineni, PhD, MPH, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.

Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.

Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.

Research interests and experience

Cancer

Cervical cancer; colorectal cancer; screening; disparities
Methods

Electronic clinical and administrative data infrastructure development for research; case-control studies; team science

Recent publications

Feldman S, Lykken JM, Haas JS, Werner CL, Kobrin SC, Tiro JA, Chubak J, Kamineni A Factors associated with timely colposcopy following an abnormal cervical cancer test result 2022 Nov;164:107307. doi: 10.1016/j.ypmed.2022.107307. Epub 2022-10-18. PubMed

Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda 2022 Aug 2;31(8):1521-1531. doi: 10.1158/1055-9965.EPI-22-0100. PubMed

Chubak J, Burnett-Hartman AN, Barlow WE, Corley DA, Croswell JM, Neslund-Dudas C, Vachani A, Silver MI, Tiro JA, Kamineni A Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval 2022 Aug 2;31(8):1517-1520. doi: 10.1158/1055-9965.EPI-22-0232. PubMed

Schottinger JE, Jensen CD, Ghai NR, Chubak J, Lee JK, Kamineni A, Halm EA, Sugg-Skinner C, Udaltsova N, Zhao WK, Ziebell RA, Contreras R, Kim EJ, Fireman BH, Quesenberry CP, Corley DA Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer 2022 Jun 7;327(21):2114-2122. doi: 10.1001/jama.2022.6644. PubMed

Feigelson HS, Clarke CL, Van Den Eeden SK, Weinmann S, Burnett-Hartman AN, Rowell S, Scott SG, White LL, Ter-Minassian M, Honda SAA, Young DR, Kamineni A, Chinn T, Lituev A, Bauck A, McGlynn EA The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship 2022 Feb 25;22(1):209. doi: 10.1186/s12885-022-09252-6. Epub 2022-02-25. PubMed

Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics 2022 Jan;154:106871. doi: 10.1016/j.ypmed.2021.106871. Epub 2021-11-08. PubMed

Silver MI, Anderson ML, Beaber EF, Haas JS, Kobrin S, Pocobelli G, Skinner CS, Tiro JA, Kamineni A De-implementation of cervical cancer screening before age 21 2021 Dec;153:106815. doi: 10.1016/j.ypmed.2021.106815. Epub 2021-09-29. PubMed

Castanon A, Kamineni A, Elfström KM, Lim AWW, Sasieni P Exposure definition in case-control studies of cervical cancer screening: a systematic literature review 2021 Dec;30(12):2154-2166. doi: 10.1158/1055-9965.EPI-21-0376. Epub 2021-09-14. PubMed

Mazor KM, Kamineni A, Roblin DW, Anau J, Robinson BE, Dunlap B, Firneno C, Gallagher TH Encouraging Patients to Speak up About Problems in Cancer Care 2021 Dec;17(8):e1278-e1284. doi: 10.1097/PTS.0000000000000510. PubMed

Puricelli Perin DM, Elfström KM, Bulliard JL, Burón A, Campbell C, Flugelman AA, Giordano L, Kamineni A, Ponti A, Rabeneck L, Saraiya M, Smith RA, Broeders MJM, International Cancer Screening Network Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey 2021 Oct;151:106642. doi: 10.1016/j.ypmed.2021.106642. Epub 2021-06-30. PubMed